AbbVie Inc. is 12.1x more valuable than Zoetis Inc. by market capitalization ($402.35 B vs $33.36 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ZTS | ABBV |
|---|---|---|
| Market cap | $33.36 B | $402.35 B |
| US-listed rank | #436 | #31 |
| Revenue (latest FY) | $9.47B | $61.16B |
| Net income (latest FY) | $2.67B | $4.23B |
| Net margin | 28.2% | 6.9% |
| P/E (trailing FY) | 12.5 | 95.2 |
| SEC filings | 2,040 | 1,008 |
AbbVie Inc. is 12.1x more valuable than Zoetis Inc. by market capitalization ($402.35 B vs $33.36 B).
In their latest fiscal years, Zoetis Inc. reported $9.47B in revenue while AbbVie Inc. reported $61.16B.
Full pages: Zoetis Inc. and AbbVie Inc., or browse the full rankings.